Ligand Pharmaceuticals Inc (NASDAQ:LGND)

Delayed Data
As of 4:00pm ET
 -0.79 / -0.47%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 154.00, with a high estimate of 170.00 and a low estimate of 112.00. The median estimate represents a -7.75% decrease from the last price of 166.94.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -51.65%
Growthannually 40.06%


Growthquarterly -51.37%
Growthannually 28.81%
Key to the earnings and sales forecast charts.